Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Signum Biosciences patents

List of Signum Biosciences patents

List of Access Scientific patents

List of Sandbridge Technologies patents

List of Bluebird patents

List of companies founded by Mark Cuban

List of 500startups Batch 1 companies

Patents where

Current Assignee

Name

is

Signum Biosciences

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11518738 Compounds and methods of use	Patent 11518738 was granted and assigned to Signum Biosciences on December, 2022 by the United States Patent and Trademark Office.	Signum Biosciences	Signum Biosciences		United States Patent and Trademark Office	11518738	December 6, 2022
	‌ US Patent 8338648 Topical compositions and methods for epithelial-related conditions	Patent 8338648 was granted and assigned to Signum Biosciences on December, 2012 by the United States Patent and Trademark Office.		Signum Biosciences		United States Patent and Trademark Office	8338648	December 25, 2012
	‌ US Patent 9744147 Isoprenyl compounds and methods thereof	Patent 9744147 was granted and assigned to Signum Biosciences on August, 2017 by the United States Patent and Trademark Office.	Signum Biosciences	Signum Biosciences		United States Patent and Trademark Office	9744147	August 29, 2017
	‌ US Patent 9486441 Compounds, compositions and methods for making the same	Patent 9486441 was granted and assigned to Signum Biosciences on November, 2016 by the United States Patent and Trademark Office.		Signum Biosciences		United States Patent and Trademark Office	9486441	November 8, 2016
	‌ US Patent 10975023 Compounds and methods of use	Patent 10975023 was granted and assigned to Signum Biosciences on April, 2021 by the United States Patent and Trademark Office.	Signum Biosciences	Signum Biosciences		United States Patent and Trademark Office	10975023	April 13, 2021
	‌ US Patent 10314817 Tryptamide compositions and methods of use	Patent 10314817 was granted and assigned to Signum Biosciences on June, 2019 by the United States Patent and Trademark Office.	Signum Biosciences	Signum Biosciences		United States Patent and Trademark Office	10314817	June 11, 2019
	‌ US Patent 9415026 Use of anti-bacterial agents for the treatment of epithelial-related conditions	Patent 9415026 was granted and assigned to Signum Biosciences on August, 2016 by the United States Patent and Trademark Office.		Signum Biosciences		United States Patent and Trademark Office	9415026	August 16, 2016
	‌ US Patent 10117904 Use of anti-bacterial agents for the treatment of epithelial-related conditions	Patent 10117904 was granted and assigned to Signum Biosciences on November, 2018 by the United States Patent and Trademark Office.	Signum Biosciences	Signum Biosciences		United States Patent and Trademark Office	10117904	November 6, 2018
	‌ US Patent 10912812 Methods for preparing botanical extracts	Patent 10912812 was granted and assigned to Signum Biosciences on February, 2021 by the United States Patent and Trademark Office.	Signum Biosciences	Signum Biosciences		United States Patent and Trademark Office	10912812	February 9, 2021
	‌ US Patent 8372884 Isoprenyl compounds and methods thereof	Patent 8372884 was granted and assigned to Signum Biosciences on February, 2013 by the United States Patent and Trademark Office.		Signum Biosciences		United States Patent and Trademark Office	8372884	February 12, 2013
	‌ US Patent 10314802 Isoprenyl compounds and methods thereof	Patent 10314802 was granted and assigned to Signum Biosciences on June, 2019 by the United States Patent and Trademark Office.	Signum Biosciences	Signum Biosciences		United States Patent and Trademark Office	10314802	June 11, 2019
	‌ US Patent 9376383 Isoprenyl compounds	Patent 9376383 was granted and assigned to Signum Biosciences on June, 2016 by the United States Patent and Trademark Office.		Signum Biosciences		United States Patent and Trademark Office	9376383	June 28, 2016
	‌ US Patent 10583119 Compounds, compositions and methods for making the same	Patent 10583119 was granted and assigned to Signum Biosciences on March, 2020 by the United States Patent and Trademark Office.	Signum Biosciences	Signum Biosciences		United States Patent and Trademark Office	10583119	March 10, 2020
	‌ US Patent 8461204 Cysteinyl compounds, compositions and methods of use	Patent 8461204 was granted and assigned to Signum Biosciences on June, 2013 by the United States Patent and Trademark Office.		Signum Biosciences		United States Patent and Trademark Office	8461204	June 11, 2013
	‌ US Patent 8334413 Topical compositions and methods for epithelial-related conditions			Signum Biosciences		United States Patent and Trademark Office	8334413	December 18, 2012
	‌ US Patent 11802107 Compounds and methods of use	Patent 11802107 was granted and assigned to Signum Biosciences on October, 2023 by the United States Patent and Trademark Office.	Signum Biosciences	Signum Biosciences		United States Patent and Trademark Office	11802107	October 31, 2023

16 results

0 selected

16 results

0 selected